Tanaka, Yoshiya http://orcid.org/0000-0002-0807-7139
Article History
Received: 8 September 2022
Accepted: 23 December 2022
First Online: 9 January 2023
Declarations
:
: Not applicable
: Not applicable
: Y. Tanaka has received speaking fees and/or honoraria from Behringer-Ingelheim, Eli Lilly, Abbvie, Gilead, AstraZeneca, Bristol-Myers, Chugai, Daiichi-Sankyo, Eisai, Pfizer, Mitsubishi-Tanabe, GlaxoSmithKline, received research grants from Asahi-Kasei, Abbvie, Chugai, Eisai, Takeda, Daiichi-Sankyo, Behringer-Ingelheim.